FDA safety and innovation act (FDASIA) support services new drug modernization implementation support

Ended Awarded Last action

Contract number
75F40119F19002
Awardee
Awarding agency
Obligated
$14,506,774

Award facts

Opportunity
Contract value 100% obligated
$14,506,773.68 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
Pricing
Time and Materials
Place of performance
Silver Spring, MD 20993, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out P00006 · The purpose of this modification is to DE-obligate funds and close out the contract. -$175,208
Other Administrative Action P00005 $1,699,911
Other Administrative Action P00004 $0
Other Administrative Action P00003 $6,083,316
Supplemental Agreement for work within scope P00002 $4,188,139
Supplemental Agreement for work within scope P00001 $0
Original award $2,710,617

About this award

This contract award is for FDA Safety and Innovation Act (FDASIA) support services to assist with the implementation of new drug modernization efforts at the Food and Drug Administration (FDA). The $14,506,773.68 contract was awarded to the prime contractor Booz Allen Hamilton Inc. on September 10, 2019, with a period of performance through December 26, 2022. The contract is a Blanket Purchase Agreement (BPA) call, with a Time and Materials pricing type. Booz Allen Hamilton is a major government contractor that has received numerous prime and subcontract awards from various federal agencies. For this effort, Booz Allen Hamilton has subcontracted with Quevera LLC, a certified 8(a) small disadvantaged business, to provide business analysis support. The award did not have a socioeconomic set-aside. This contract supports the FDA's mission to ensure the safety and efficacy of new drugs brought to market.

Quick answers

Who was awarded contract 75F40119F19002?

75F40119F19002 was awarded to Booz Allen Hamilton Inc. by Food and Drug Administration (Department of Health and Human Services) on September 10, 2019.

How much is contract 75F40119F19002 worth?

The government has obligated $14,506,774 on 75F40119F19002.

Is contract 75F40119F19002 an order under another contract?

Yes. 75F40119F19002 is a BPA call under GS00F008DA-HHSF223201610017B, a blanket purchase agreement, on FDA Safety And Innovation Act Support Services (FDASIA).

Was contract 75F40119F19002 competed?

The extent of competition for 75F40119F19002 was full and open competition. The government received 2 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award